Skip to content
TrialX Logo
  • Home
  • Categories
    • Patient Recruitment
    • Clinical Trial Awareness
    • Remote Data Collection
    • Patient Engagement
    • Product Release
  • Solutions
    • iConnect – Patient Recruitment Management
    • xPAND – Remote Data Collection
    • CureTalks – Raise Awareness
  • Resources
    • Blogs
    • Press
    • Webinars
  • About Us
    • Team
    • Careers
  • Contact Us
  • Patient Recruitment
  • Clinical Trial Awareness
  • Remote Data Collection
  • Patient Engagement
  • Product Release
Share

Fertility Preservation and Treatment Options for Women Diagnosed with Cervical Cancer

March 25th, 2019 •
♥3
Fertility Preservation and Treatment Options for Women Diagnosed with Cervical Cancer
January 30, 2019
UPCOMING/Recent Talks

Fertility Preservation and Treatment Options for Women Diagnosed with Cervical Cancer

with  Dr. Julie Lamb 
January 28, 2019, 5:30 PM EST LISTEN
Nearly 13000 women are diagnosed with cervical cancer in the United States each year and about 68% of all invasive cervical cancer cases diagnosed involve women of childbearing age. Advanced treatments available today allow women to live longer but the same treatments impact their fertility negatively, decreasing their quality of life severely. This makes it important that these women be given options to preserve their fertility before going for cervical cancer treatments. January is Cervical Cancer awareness month, and in honor we are addressed the issue of fertility preservation in cervical cancer patients with Dr Julie Lamb, reproductive endocrinologist and infertility specialist at Pacific NW Fertility in Seattle and clinical faculty at the University of Washington. Morgan and Lauren, Cervical cancer ambassadors for Cervivor.org and Allison Pozzi, a Cervical cancer survivor who successfully built her family via IVF (In vitro fertilisation) also share their experiences and informed the panel.
Panelists
Dr. Julie Lamb
Morgan S Newman
Allison Pozzi
 
Lauren Lastauskas
Shweta Mishra
January 4th, 2018. 11 AM EST
LISTEN
The treatment paradigm for myeloma patients has changed in the last decade with important advancements such as proteasome inhibitors, IMiDS, antibodies and risk-adapted maintenance. How a patient responds to therapy can be used to determine how long the maintenance or follow-up therapy should be. This is called risk-adapted therapy and personalizes myeloma care. The myeloma panel talked to Dr. Sagar Lonial of Winship Cancer Institute of Emory University, to learn how he uses genetic and disease risk factors to personalize maintenance strategies after stem cell transplants for his patients with multiple myeloma.





Panelists
Dr. Sagar Lonial  
Gary Petersen
Jack Aiello
Yelak Biru
Priya Menon 
December 19, 2018. 10 AM EST LISTEN
Polycystic ovary syndrome (PCOS) is a health condition that affects 1 in 10 women of childbearing age. Women with PCOS have hormonal imbalance & metabolism problems that may lead to obesity, CVD, type 2 diabetes, infertility, endometrial cancer and more. In the absence of a complete cure, efficient management of the condition gains importance and information is the key. We talked to a panel of experts from the University of Pennsylvania - Dr. Anuja Dokras, Dr. Anastassia Amaro & Dr. Kelly Costello Allison to understand the condition, available treatments, and best ways to manage symptoms. The discussion also touched upon the details of the PCOS-COMET study being conducted by Penn PCOS Center to compare the effects of medications on metabolic risk factors such as weight, blood pressure, glucose, & cholesterol levels in overweight/obese women.
Panelists
Dr Anuja Dokras
Dr. Anastassia Amaro
Dr. Kelly Costello Allison
Valerie Landis 
Priya Menon 
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Our Picks
Story The Cancer Armamentarium: Immunotherapy in the Forefront
WIDGET Find your Clinical Trials on Centerwatch.com! Powered by TrialX iConnect
Categories:
Tags: #MobiClin2018 , 2016 , ACRP2017 , active task , active task on ios , active tasks on android , AI , amia , AMIA 2016 , amia 2017 , AMIA2016 , AMIA2017 , amputee pain , Android , android apps , android research study apps , Android ResearchKit , app builder , app surveys , appbakery , apple active task , Apple ResearchKit , apps , Artificial Intelligence , ASCO 2017 , ask Dory , barriers in mhealth , BigData , brain initiative , Cancer , cancer immunotherapy , cancer moonshot , cancer novartis , Cancer treatment , car t cancer , car t clinical trials , car t durgs , car t pharmas , CAR-T cell therapy , car-t immunotherapy , carekit , Carl June , cellectar , centerwatch , challenges mhealth adoption , chatbots , clinical , clinical research , clinical trial digital tools , clinical trial failure , clinical trial finder , clinical trial losses , clinical trial management , clinical trial management system , clinical trial management systems , clinical trial participation , clinical trial sponsors , clinical trial website builder , clinical trials , clinical trials eligibility criteria , clinical trials participation , clinical trials recruitment , clinical trials upenn , clinicalresearch , clinicaltrials , clinicaltrialvolunteers , conference 2016 , conference 2017 , conference 2023 , consent under gdpr , Coronavirus , covid talk series with Penn Medicine , covid trials , COVID-19 , COVID-19 Cure , COVID19 , covid19 clinical trials , COVID19 therapy , COVID19 vaccine , Creative writing , crossplatform apps , ctms , ctms trialx , Cure , curetalks@penn , data privacy , DCT , Decentralised clinical trials , decentralized research , decentralized trials , DEI Toolkit , depression , DIA , DIA 2016 , DIA2017 , digital patient engagement , disruptive innovations , diversity , diversity in clinical trials , DIY appmaking platform , DIY study apps , dpharm , DPharm 2016 , Dpharm2016 , dpharm2017 , drug development , drugs in 2016 , e-consent , EHR , electronic patient reported outcomes , ePRO , equity , equity in clinical trials , facebook , fda , FDA approvals , fda drug approval process , fda drug approved in 2016 , Federal data , finger tapping researchkit , games , gamification , GDPR , genome hacking , gregory dumanian , Hackathon , Halloween , healthcare , healthy controls , healthy subjects , healthy volunteers , human atlas , human cell atlas , iconnect , iconnect clinical trial , iConnect features , IDY , Immunotherapy , immunotherapy cancer , inclusion , inclusion in clinical trials , indiana clinical trials , informatics , informed consent , Inspiration , internationalization in research study apps , investment , iOS , ios apps , key fda drugs , limb loss pain , Lyme , lyme diagnosis , Lyme disease , lyme disease management , Lyme disease tracker app , lyme symptoms , medical apps , Mega projects , mental health , mental health clinical trials , mhealth , mhealth adoption , mhealth in clinical trials , mhealth precision medicine , mhealth tools , milestone , minority participation , mobile apps , mobile clinical innovations , mobile health technology in engagment , mobile in clinical trials , Mobile Research , Mobile Research Apps , mobile research study app , mobile research study apps , mobileclin2017 , mobileclin2022 , multi-language apps , multi-language research apps , my clinical trial story , neurogenic pain , new data privacy policy , new release , new video format , northwestern university , novel coronavirus , NYU , nyu clinical trials , online talk shows , orphan drugs , pain app , patient , patient centric , patient centricity , patient engagement , patient engagement in clinical trials , patient generated health data , patient involvement , patient participation , patient portals , Patient Recruitment , patient referrals , patient reported outcomes , patientengagement , patientfocussed , patients , penn clinical trials , Penn Medicine , personal health information gdpr , Philadelphia , precision medicine , prompts , rare disease , Recruitment Tools , remote data , remote data collection , research , research apps , research study apps , Research Volunteers , ResearchDroid , researchkit , researchkit active task , researchkit active task list , researchkit active tasks , researchkit android , researchkit apps , rett syndrome trials , Sars-Cov-2 , SARS-COV2 , SCOPE2018 , scope2023 , scopesummit , sellas life sciences , sleep self management , sleep study , sleep tracking , sleep tracking app , small biotech companies , Social Media , space health research , spaceflights , spacehealth , spaceresearch , study apps , Team building , Team Outing , Team Retreat , The Opportunity Project , tokenization , TOP Health Challenge , tophealth , tophealthchallenge , track sleep , trial participation and engagment , trialspace , trialx , trialx iconnect , trump fda , twitter , U.S. Elections , University of Pennsylvania , Upenn , Virology , volunteer registry , Webinars , Website Builder , White House , world yoga day , year end review , year2022 ,
0
23273

TrialX Editor

View all posts by TrialX Editor

Post navigation

Previous: TrialX at the White House TOP Health Showcase Event
Next: Revolutionizing Patient Recruitment & Engagement with iConnect

About TrialX

TrialX is a clinical research and space health informatics company headquartered in New York City. From launching the first clinical trials app on Google Health in 2008, to powering online patient recruitment and research data collection for space missions, TrialX is empowering clinical research here on earth and beyond.

Subscribe

Related Posts

June 2nd, 2023 Clinical Trial Awareness, Patient Engagement, Patient recruitment, Remote Data Collection

Ax-2 Mission Landed Safely! TrialX xPAND Supports TRISH for Pre & Post Flight Data Collection

The Axiom-2 mission successfully launched on May 21, 2023 and we are proud to be a part of this historic mission supporting it’s pre-flight and post-flight data collection with the TrialX xPAND app. The xPAND team…

Shweta Mishra
♥10
May 8th, 2023 Clinical Trial Awareness, Patient Engagement, Patient recruitment, Remote Data Collection

🚀 TrialX xPAND Supports Data Collection For Axiom-2 Mission 

The Axiom-2 mission is scheduled to launch on May 17, 2023 and pre-flight and post-flight data collection will be supported by the TrialX xPAND app. Our xPAND team is working tirelessly to ensure that the crew…

Shweta Mishra
♥30
April 3rd, 2023 Clinical Trial Awareness, Patient Engagement, Patient recruitment, Remote Data Collection

iConnect powers RECOVER study, xPAND @ UPenn Clinical Research Forum Week

🚀  iConnect powers the RECOVER study TrialX iConnect is proud to support RECOVER (Researching COVID to Enhance Recovery), a nationwide initiative dedicated to understanding, treating, and preventing Long COVID. Our award winning patient recruitment management system will help…

Shweta Mishra
♥96

About

TrialX is a clinical research and space health informatics company headquartered in New York City. From launching the first clinical trials app on Google Health in 2008, to powering online patient recruitment and research data collection for space missions, TrialX is empowering clinical research here on earth and beyond.

Latest Posts

  • June 2nd, 2023

    Ax-2 Mission Landed Safely! TrialX xPAND Supports TRISH for Pre & Post Flight Data Collection

  • May 8th, 2023

    🚀 TrialX xPAND Supports Data Collection For Axiom-2 Mission 

  • April 3rd, 2023

    iConnect powers RECOVER study, xPAND @ UPenn Clinical Research Forum Week

  • February 28th, 2023

    Human Health in Space Missions, Decentralized Clinical Trials Webinar, Welcoming New Members and More…

Follow Us

    Copyright 2023 TrialX. All Rights Reserved.